Combined Treatment of Heteronemin and Tetrac Induces Antiproliferation in Oral Cancer Cells

Background: Heteronemin, a marine sesterterpenoid-type natural product, possesses an antiproliferative effect in cancer cells. In addition, heteronemin has been shown to inhibit p53 expression. Our laboratory has demonstrated that the thyroid hormone deaminated analogue, tetrac, activates p53 and in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mar Drugs
Main Authors: Huang, Chi-Hung, Huang, Tung-Yung, Chang, Wong-Jin, Pan, Yi-shin, Chu, Hung-Ru, Li, Zi-Lin, Unson, Sukanya, Chin, Yu-Tang, Lin, Chi-Yu, Huang, Haw-Ming, Hsiung, Chao-Nan, Gionfra, Fabio, De Vito, Paolo, Pedersen, Jens Z., Incerpi, Sandra, Chen, Yi-Ru, Lee, Sheng-Yang, Lin, Hung-Yun, Davis, Paul J., Whang-Peng, Jacqueline, Wang, Kuan
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7401260/
https://ncbi.nlm.nih.gov/pubmed/32630719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/md18070348
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados